Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$0.48 - $13.5 $45,840 - $1.29 Million
-95,500 Closed
0 $0
Q3 2022

Oct 13, 2022

SELL
$0.79 - $22.0 $2,879 - $80,190
-3,645 Reduced 3.68%
95,500 $0
Q4 2021

Feb 02, 2022

BUY
$2.42 - $3.65 $239,930 - $361,879
99,145 New
99,145 $247,000
Q4 2019

Feb 26, 2020

SELL
$1.25 - $2.57 $98,937 - $203,415
-79,150 Closed
0 $0
Q3 2019

Nov 15, 2019

BUY
$1.26 - $1.96 $99,729 - $155,134
79,150 New
79,150 $111,000

Others Institutions Holding FBIO

About Fortress Biotech, Inc.


  • Ticker FBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,735,000
  • Market Cap $205M
  • Description
  • Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...
More about FBIO
Track This Portfolio

Track Pvg Asset Management Corp Portfolio

Follow Pvg Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pvg Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Pvg Asset Management Corp with notifications on news.